Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The averages reflect trends, not guarantees for any individual
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
Achieve lasting weight loss with GLP-1
Gastrointestinal side effects are the most common on Wegovy or Ozempic
Its essential to discuss risk and benefits with your healthcare provider and to be aware of the potential side effect in order to manage them effectively: Nausea and vomiting : These are the most common side effects and usually decrease over time
US$ 26.46
US$ 21.33
US$ 26.53
